Trial intelligence / Profile preview

Hypertonic Saline vs Ringer Lactate for RV Function in Cardiac Surgery

NCT02782520Phase 3Completed

Sponsor
CHU Grenoble Alpes
Start
Aug 2016
Primary completion
Oct 2017
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of hypertonic saline in hypovolemia and Right ventricular dysfunction (RVD) (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Right ventricular ejection fraction change. Started Aug 2016; status: completed.

02

Drugs

hypertonic saline
03

Conditions

hypovolemiaRight ventricular dysfunction (RVD)

Beyond the preview

Go deeper on NCT02782520.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02782520.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call